Pandite Arundathy N.
Chief Medical Officer
Pandite Arundathy N. has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Jul 2, 2026.
On the most recent filing, Pandite Arundathy N. is listed as Chief Medical Officer at Shattuck Labs, Inc. Inside the rolling window, Pandite Arundathy N. reported no open-market purchases and 2 open-market sales totaling $409K in STTK. The largest disclosed transaction in the window is a sale of 30,000 STTK shares on Jun 30, 2026, worth $210K.
Companies traded
Other insiders at STTK
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$409K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Pandite Arundathy N. made?
Pandite Arundathy N. has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Pandite Arundathy N. trade?
Pandite Arundathy N. has filed SEC Form 4 disclosures for 1 company, including STTK.
When was Pandite Arundathy N.'s most recent SEC Form 4 filing?
Pandite Arundathy N.'s most recent SEC Form 4 filing on Tracefour is dated Jul 2, 2026.
What is Pandite Arundathy N.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Pandite Arundathy N. is listed as Chief Medical Officer.
What is Pandite Arundathy N.'s total buy and sell value in the current window?
Inside the rolling retention window, Pandite Arundathy N. bought $0 and sold $409K based on SEC Form 4 filings.
What was Pandite Arundathy N.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 30,000 STTK shares on 2026-06-30, worth $210K, per SEC Form 4 filings.